Association of haplotypes of inflammation-related genes with gastric preneoplastic lesions in African Americans and Caucasians

International Journal of Cancer

Volumn 128, Issue 3, 2011, Pages 668-675

  Zabaleta, Jovanny ^a   Camargo, Maria C ^b   Ritchie, Marylyn D ^c   Piazuelo, Maria B ^b   Sierra, Rosa A ^a   Turner, Stephen D ^c   Delgado, Alberto ^b   Fontham, Elizabeth T H ^d   Schneider, Barbara G ^b   Correa, Pelayo ^b   Ochoa, Augusto C ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

gastric inflammatory lesions; Helicobacter pylori; inflammation; single nucleotide polymorphisms

Indexed keywords

ARGINASE 1; CAGA PROTEIN; CYCLOOXYGENASE 2; GENOMIC DNA; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AFRICAN AMERICAN; ALLELE; ARG1 GENE; ARTICLE; CARCINOGENESIS; CAUCASIAN; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GASTROSCOPY; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IL10 GENE; IL1B GENE; IL6 GENE; IL8 GENE; INFLAMMATION; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; PTGS2 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH BIOPSY; STOMACH CANCER; TGFB1 GENE; TNF GENE; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; DNA, NEOPLASM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GASTRIC MUCOSA; HAPLOTYPES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; INTERLEUKIN-18; LOUISIANA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS;

EID: 78649885665     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25385     Document Type: Article

References (49)

1. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ,. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66.
3. Surveillance Epidemiology and End Results. Cancer Facts Statistics, SEER. National Cancer Institute 2008. Available from:. Accessed April 10, 2008.
4. Hold GL, El-Omar EM,. Genetic aspects of inflammation and cancer. Biochem J 2008; 410: 225-35.
5. Schottenfeld D, Beebe-Dimmer J,. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 2006; 56: 69-83.
6. IARC. IARC monograph on the evaluation of carcinogenic risks to humans: schistosomes, liver flukes and Helicobacter pylori, vol. 61. Lyon, France: IARC, 1994. p. 177-240.
7. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M,. A model for gastric cancer epidemiology. Lancet 1975; 2: 58-60.
8. Fox JG, Wang TC,. Inflammation, atrophy, and gastric cancer. J Clin Invest 2007; 117: 60-9.
9. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A,. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-5.
10. Peek RM Jr, Miller GG, Tham KT, Perez-Perez GI, Zhao X, Atherton JC, Blaser MJ,. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 1995; 73: 760-70.
11. Sicinschi LA, Lopez-Carrillo L, Camargo MC, Correa P, Sierra RA, Henry RR, Chen J, Zabaleta J, Piazuelo MB, Schneider BG,. Gastric cancer risk in a Mexican population: role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and -10 genes. Int J Cancer 2006; 118: 649-57.
12. Camargo MC, Mera R, Correa P, Peek RM Jr, Fontham ET, Goodman KJ, Piazuelo MB, Sicinschi L, Zabaleta J, Schneider BG,. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 1674-87.
13. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402.
14. Gorouhi F, Islami F, Bahrami H, Kamangar F,. Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis. Br J Cancer 2008; 98: 1443-51.
15. Kroeger KM, Carville KS, Abraham LJ, The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997; 34: 391-9.
16. Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredo C, Amorim A, Seruca R, Caldas C, Carneiro F, Sobrinho-Simoes M,. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001; 121: 823-9.
17. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J,. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992; 22: 396-402.
18. Zabaleta J, Camargo MC, Piazuelo MB, Fontham E, Schneider BG, Sicinschi LA, Ferrante W, Balart L, Correa P, Ochoa AC,. Association of interleukin-1beta gene polymorphisms with precancerous gastric lesions in African Americans and Caucasians. Am J Gastroenterol 2006; 101: 163-71.
19. Savage SA, Abnet CC, Mark SD, Qiao YL, Dong ZW, Dawsey SM, Taylor PR, Chanock SJ,. Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2004; 13: 2251-7.
20. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni JF Jr, Chow WH,. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124: 1193-201.
21. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P,. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-76.
22. Kamangar F, Abnet CC, Hutchinson AA, Newschaffer CJ, Helzlsouer K, Shugart YY, Pietinen P, Dawsey SM, Albanes D, Virtamo J, Taylor PR,. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 2006; 17: 117-25.
23. Garcia-Gonzalez MA, Strunk M, Piazuelo E, Benito R, Santolaria S, Jimenez P, Sopena F, Pascual C, Simon MA, Sainz R, Lanas A,. TGFB1 gene polymorphisms: their relevance in the susceptibility to Helicobacter pylori-related diseases. Genes Immun 2006; 7: 640-6.
24. Jin G, Wang L, Chen W, Hu Z, Zhou Y, Tan Y, Wang J, Hua Z, Ding W, Shen J, Zhang Z, Wang X, et al. Variant alleles of TGFB1 and TGFBR2 are associated with a decreased risk of gastric cancer in a Chinese population. Int J Cancer 2007; 120: 1330-5.
25. McCarthy CJ, Crofford LJ, Greenson J, Scheiman JM,. Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection. Am J Gastroenterol 1999; 94: 1218-23.
26. Liu F, Pan K, Zhang X, Zhang Y, Zhang L, Ma J, Dong C, Shen L, Li J, Deng D, Lin D, You W,. Genetic variants in cyclooxygenase-2: expression and risk of gastric cancer and its precursors in a Chinese population. Gastroenterology 2006; 130: 1975-84.
27. Rodriguez PC, Quiceno DG, Zabaleta J, Ortiz B, Zea AH, Piazuelo MB, Delgado A, Correa P, Brayer J, Sotomayor EM, Antonia S, Ochoa JB, et al. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res 2004; 64: 5839-49.
28. Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ, Rafie-Kolpin M, Hsieh CM, et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 2006; 15: 519-29.
29. Schneider BG, Camargo MC, Ryckman KK, Sicinschi LA, Piazuelo MB, Zabaleta J, Correa P, Williams SM,. Cytokine polymorphisms and gastric cancer risk: an evolving view. Cancer Biol Ther 2007; 7: 157-62.
30. Terry CF, Loukaci V, Green FR,. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000; 275: 18138-44.
31. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG,. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002; 53: 79-91.
32. Dixon MF, Genta RM, Yardley JH, Correa P,. Classification and grading of gastritis. The updated Sydney System International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.
33. Rugge M, Correa P, Dixon MF, Hattori T, Leandro G, Lewin K, Riddell RH, Sipponen P, Watanabe H,. Gastric dysplasia: the Padova international classification. Am J Surg Pathol 2000; 24: 167-76.
34. Garvey W, Fathi A, Bigelow F,. Modified Steiner for the demonstration of spirochetes. J Histotechnol 1985; 8: 15-7.
35. Van Doorn LJ, Figueiredo C, Sanna R, Pena S, Midolo P, Ng EK, Atherton JC, Blaser MJ, Quint WG,. Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol 1998; 36: 2597-603.
36. Sicinschi LA, Correa P, Bravo LE, Schneider BG,. A positive assay for identification of cagA negative strains of Helicobacter pylori. J Microbiol Methods 2003; 55: 625-33.
37. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA, Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425-34.
38. Barrett JC, Fry B, Maller J, Daly MJ,. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-5.
39. Con SA, Con-Wong R, Con-Chin GR, Con-Chin VG, Takeuchi H, Valerin AL, Echandi G, Mena F, Brenes F, Yasuda N, Araki K, Sugiura T,. Serum pepsinogen levels Helicobacter pylori Cag A Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica. Cancer Epidemiol Biomarkers Prev 2007; 16: 2631-6.
40. Alpizar-Alpizar W, Perez-Perez GI, Une C, Cuenca P, Sierra R,. Association of interleukin-1B and interleukin-1RN polymorphisms with gastric cancer in a high-risk population of Costa Rica. Clin Exp Med 2005; 5: 169-76.
41. Beales IL, Calam J,. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 1998; 42: 227-34.
42. El-Omar EM, The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut 2001; 48: 743-7.
43. Rozengurt E, Walsh JH,. Gastrin CCK, signaling, and cancer. Annu Rev Physiol 2001; 63: 49-76.
44. Loh M, Koh KX, Yeo BH, Song CM, Chia KS, Zhu F, Yeoh KG, Hill J, Iacopetta B, Soong R,. Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race. Eur J Cancer 2009; 45: 2562-8.
45. Dan YY, So JB, Yeoh KG,. Endoscopic screening for gastric cancer. Clin Gastroenterol Hepatol 2006; 4: 709-16.
46. Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, Wu KC, Wu DC, Sollano J, Kachintorn U, Gotoda T, Lin JT, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008; 9: 279-87.
47. Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, Doi H, Yoshida H, Kawabe T, Omata M,. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005; 54: 764-8.
48. Chapman NH, Wijsman EM,. Genome screens using linkage disequilibrium tests: optimal marker characteristics and feasibility. Am J Hum Genet 1998; 63: 1872-85.
49. Ott J, Rabinowitz D,. The effect of marker heterozygosity on the power to detect linkage disequilibrium. Genetics 1997; 147: 927-30.